Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States
Kidney Med
.
2022 Dec 15;5(1):100590.
doi: 10.1016/j.xkme.2022.100590.
eCollection 2023 Jan.
Authors
Susanne B Nicholas
1
,
Radica Z Alicic
2
3
,
Jenny Shen
4
Affiliations
1
Department of Medicine, Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, California.
2
Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington.
3
Department of Medicine, University of Washington, Seattle, Washington.
4
Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.
PMID:
36605084
PMCID:
PMC9807823
DOI:
10.1016/j.xkme.2022.100590
No abstract available
Publication types
Editorial